JENNIFER FLEIGELMAN: Open Payments
NPI 1790405405 · DELRAY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,399 in 32 payments from 12 companies in 2025. Trend: 2023 $637 · 2024 $1,307 · 2025 $1,399
Food & beverage: $1,399
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $392 |
| AstraZeneca Pharmaceuticals LP | 6 | $268 |
| Gilead Sciences, Inc. | 2 | $133 |
| Neurocrine BioSciences, Inc. | 1 | $127 |
| Axsome Therapeutics, Inc. | 1 | $122 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $116 |
| ABBVIE INC. | 4 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $71 |
| Astellas Pharma US Inc | 1 | $32 |
| PFIZER INC. | 1 | $29 |
Products named: AIRSUPRA, Wegovy, INGREZZA, Symbravo, Epclusa, UBRELVY, Veozah, Ozempic.
Industry payments across FL — which companies pay providers there.
